Sign In
Buy CRIS
$0.500
-0.0025 (-0.498%)
At Close: Jun 03, 2026
Mid-Morning Market Update: Markets Mostly Lower; United Natural Foods Earnings Beat Views
02:21pm, Wednesday, 10'th Jun 2020Curis Announces FDA Clearance Of IND Application For CI-8993 Monoclonal Anti-VISTA Antibody
12:08pm, Wednesday, 10'th Jun 2020Curis Announces FDA Clearance of IND Application for CI-8993, the First-In-Class Monoclonal Anti-VISTA Antibody
12:00pm, Wednesday, 10'th Jun 2020
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA)
20 Healthcare Stocks Moving In Wednesday's Pre-Market Session
11:35am, Wednesday, 10'th Jun 2020The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset
11:30am, Wednesday, 10'th Jun 2020Do Hedge Funds Love Curis, Inc. (CRIS)?
11:24pm, Thursday, 04'th Jun 2020
In this article you are going to find out whether hedge funds think Curis, Inc. (NASDAQ:CRIS) is a good investment right now. We like to check what the smart money thinks first before doing extensive
Edited Transcript of CRIS earnings conference call or presentation 19-Mar-20 8:30pm GMT
01:33pm, Wednesday, 03'rd Jun 2020
Q4 2019 Curis Inc Earnings Call
Amazon donates 950 tablets to West Haven middle school
04:00am, Sunday, 24'th May 2020
West Haven middle school principal Rob Bohan didn't believe his ears at first when he learned Amazon was donating Kindle Fires to his school to help with distance learning.
Curis Reports First Quarter 2020 Financial Results
08:01pm, Tuesday, 12'th May 2020
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its financial results for the first quarter ended
May 11, 2020 (The Expresswire) --
Global “Histone Deacetylase (Hdac) Inhibitors Market ” analysis 2020 covers the entire supply chain, focusing on supply,...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
